Format

Send to

Choose Destination
Front Immunol. 2015 Apr 15;6:167. doi: 10.3389/fimmu.2015.00167. eCollection 2015.

Autoantibodies in systemic sclerosis: unanswered questions.

Author information

1
Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo , São Paulo , Brazil.
2
Faculty of Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB , Canada.

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular abnormalities, and cutaneous and visceral fibrosis. Serum autoantibodies directed to multiple intracellular antigens are present in more than 95% of patients and are considered a hallmark of SSc. They are helpful biomarkers for the early diagnosis of SSc and are associated with distinctive clinical manifestations. With the advent of more sensitive, multiplexed immunoassays, new and old questions about the relevance of autoantibodies in SSc are emerging. In this review, we discuss the clinical relevance of autoantibodies in SSc emphasizing the more recently published data. Moreover, we will summarize recent advances regarding the stability of SSc autoantibodies over the course of disease, whether they are mutually exclusive and their potential roles in the disease pathogenesis.

KEYWORDS:

anti-nuclear antibodies; autoantibodies; autoimmune diseases; scleroderma; systemic sclerosis

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center